- Home
- LFCR vs MRVI Comparison
LFCR vs MRVI Comparison
Compare LFCR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- MRVI
- Stock Information
- Founded
- LFCR 1986
- MRVI 2014
- Country
- LFCR United States
- MRVI United States
- Employees
- LFCR N/A
- MRVI N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- LFCR Health Care
- MRVI Health Care
- Exchange
- LFCR Nasdaq
- MRVI Nasdaq
- Market Cap
- LFCR 308.8M
- MRVI 371.8M
- IPO Year
- LFCR N/A
- MRVI 2020
- Fundamental
- Price
- LFCR $7.61
- MRVI $2.42
- Analyst Decision
- LFCR Buy
- MRVI Hold
- Analyst Count
- LFCR 4
- MRVI 10
- Target Price
- LFCR $8.00
- MRVI $5.84
- AVG Volume (30 Days)
- LFCR 108.3K
- MRVI 1.5M
- Earning Date
- LFCR 08-07-2025
- MRVI 08-11-2025
- Dividend Yield
- LFCR N/A
- MRVI N/A
- EPS Growth
- LFCR N/A
- MRVI N/A
- EPS
- LFCR N/A
- MRVI N/A
- Revenue
- LFCR $128,867,000.00
- MRVI $219,830,000.00
- Revenue This Year
- LFCR $4.78
- MRVI N/A
- Revenue Next Year
- LFCR $12.02
- MRVI $7.23
- P/E Ratio
- LFCR N/A
- MRVI N/A
- Revenue Growth
- LFCR 0.47
- MRVI N/A
- 52 Week Low
- LFCR $3.68
- MRVI $1.67
- 52 Week High
- LFCR $8.85
- MRVI $9.60
- Technical
- Relative Strength Index (RSI)
- LFCR 53.94
- MRVI 49.60
- Support Level
- LFCR $7.33
- MRVI $2.28
- Resistance Level
- LFCR $7.73
- MRVI $2.47
- Average True Range (ATR)
- LFCR 0.30
- MRVI 0.14
- MACD
- LFCR 0.03
- MRVI -0.01
- Stochastic Oscillator
- LFCR 65.33
- MRVI 27.45
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.